Munc18-1 and -2 double knockdown PC12 cells

University Health Network - Technology Development and Commercialization
posted on 03/12/2012

Available for licensing: Munc 18-1 and Munc 18-2 double knockdown PC12 cells.

Innovation Details

Detailed Description

"Munc18-1 binds to syntaxin-1A via two distinct sites referred to as the ‘closed’ conformation and Nterminus binding. The latter has been shown to stimulate SNARE-mediated exocytosis, whereas the former is believed to be inhibitory or dispensable. To precisely define the contributions of each binding mode, we have engineered Munc18-1/-2 double knockdown neurosecretory cells and show that not only syntaxin-1A and -1B but also syntaxin-2 and -3 were significantly reduced as a result of Munc18-1 and - 2 knockdown."

File Number: MD-PC12 

IP Protection

License Online

This innovation currently is not available for online licensing. Please contact Yuan Lew at University Health Network - Technology Development and Commercialization for more information.

Request more info via email request more info

Case Manager:

Yuan Lew Yuan Lew

Innovations (37)

Download Technology Brief (PDF)

Followed By

Follow this innovation

No one is following this innovation.

Related Tags

Find more innovations

February 11, 2009

13,555 members 17,732 innovations 176 organizations


Linda L. Restifo, M.D., Ph.D. - University of Arizona

"I want to say again how happy I am about the iBridge Network mechanism. This seems ideal for NeuronMetrics and I'm very pleased we will be part of this venture."  read more...